- Occult hepatitis B virus infection: clearance or disguise?
-
Kim JW
- KMID: 2069760
- Clin Mol Hepatol.
- 2014 Sep;20(3):249-250.
- doi: 10.3350/cmh.2014.20.3.249
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Sarcomatoid hepatocellular carcinoma with mixed osteoclast-like giant cells and chondroid differentiation
-
Lee KB
- KMID: 2069770
- Clin Mol Hepatol.
- 2014 Sep;20(3):313-316.
- doi: 10.3350/cmh.2014.20.3.313
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A case of small hepatocellular carcinoma with an extensive lymph node metastasis at diagnosis
-
Hong YM, Yoon KT, Cho M, Heo J, Woo HY, Lim W
- KMID: 2069769
- Clin Mol Hepatol.
- 2014 Sep;20(3):310-312.
- doi: 10.3350/cmh.2014.20.3.310
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction of fibrosis progression in chronic viral hepatitis
-
Wong GL
- KMID: 2069758
- Clin Mol Hepatol.
- 2014 Sep;20(3):228-236.
- doi: 10.3350/cmh.2014.20.3.228
Prediction of liver fibrosis progression has a key role in the management of chronic viral hepatitis, as it will be translated into the future risk of cirrhosis and its various... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors affecting drug-induced liver injury: antithyroid drugs as instances
-
Heidari R, Niknahad H, Jamshidzadeh A, Abdoli N
- KMID: 2069759
- Clin Mol Hepatol.
- 2014 Sep;20(3):237-248.
- doi: 10.3350/cmh.2014.20.3.237
Methimazole and propylthiouracil have been used in the management of hyperthyroidism for more than half a century. However, hepatotoxicity is one of the most deleterious side effects associated with these... -
- CITED
-
- Close
- SHARE
-
- Close
- A synchronous hepatocellular carcinoma and renal cell carcinoma treated with radio-frequency ablation
-
Lee YS, Kim JH, Yoon HY, Choe WH, Kwon SY, Lee CH
- KMID: 2069768
- Clin Mol Hepatol.
- 2014 Sep;20(3):306-309.
- doi: 10.3350/cmh.2014.20.3.306
Radio-frequency ablation (RFA) is a curative treatment for hepatocellular carcinoma (HCC). Percutaneous RFA has been shown to be beneficial for patients with small renal cell carcinoma (RCC) lacking indications for... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy induced liver abnormalities: an imaging perspective
-
Sharma A, Houshyar R, Bhosale P, Choi JI, Gulati R, Lall C
- KMID: 2069771
- Clin Mol Hepatol.
- 2014 Sep;20(3):317-326.
- doi: 10.3350/cmh.2014.20.3.317
Treating patients undergoing chemotherapy who display findings of liver toxicity, requires a solid understanding of these medications. It is important for any clinician to have an index of suspicion for... -
- CITED
-
- Close
- SHARE
-
- Close
- Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers
-
Kim KH, Chang HY, Park JY, Park ES, Park YK, Han KH, Ahn SH
- KMID: 2069761
- Clin Mol Hepatol.
- 2014 Sep;20(3):251-260.
- doi: 10.3350/cmh.2014.20.3.251
BACKGROUND/AIMS: Occult HBV infection can persist following HBsAg loss and be transmitted, but the virological features are not well defined. METHODS: Here we investigated 25 Korean patients who lost HBsAg during... -
- CITED
-
- Close
- SHARE
-
- Close
- Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with 90Y microspheres
-
Yim SY, Kim JD, Jung JY, Kim CH, Seo YS, Yim HJ, Um SH, Ryu HS, Kim YH, Kim CS, Shin E
- KMID: 2069767
- Clin Mol Hepatol.
- 2014 Sep;20(3):300-305.
- doi: 10.3350/cmh.2014.20.3.300
Transcatheter arterial radioembolization (TARE) with Yttrium-90 (90Y)-labeled microspheres has an emerging role in treatment of patients with unresectable hepatocellular carcinoma. Although complication of TARE can be minimized by aggressive pre-evaluation... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
-
Kim JH, Moon HW, Ko SY, Choe WH, Kwon SY
- KMID: 2069764
- Clin Mol Hepatol.
- 2014 Sep;20(3):274-282.
- doi: 10.3350/cmh.2014.20.3.274
BACKGROUND/AIMS: Quantitation of hepatitis B surface antigen (HBsAg) is an increasingly popular method to determine the treatment response in chronic hepatitis B (CHB) patients. The clinical value of HBsAg level... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk stratification of HBV infection in Asia-Pacific region
-
Kao JH
- KMID: 2069757
- Clin Mol Hepatol.
- 2014 Sep;20(3):223-227.
- doi: 10.3350/cmh.2014.20.3.223
Hepatitis B virus (HBV) infection is the major etiology of chronic liver disease worldwide and thus a global health problem, especially in Asia-Pacific region. The long-term outcomes of Asian HBV... -
- CITED
-
- Close
- SHARE
-
- Close
- Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naive chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
-
Ahn SS, Chon YE, Kim BK, Kim SU, Kim DY, Ahn SH, Han KH, Park JY
- KMID: 2069762
- Clin Mol Hepatol.
- 2014 Sep;20(3):261-266.
- doi: 10.3350/cmh.2014.20.3.261
BACKGROUND/AIMS: This study assessed the antiviral efficacy and safety of tenofovir disoproxil fumarate (TDF) for up to 12 months in Korean treatment-naive chronic hepatitis B (CHB) patients. METHODS: A total of... -
- CITED
-
- Close
- SHARE
-
- Close
- The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleeding
-
Je D, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC
- KMID: 2069765
- Clin Mol Hepatol.
- 2014 Sep;20(3):283-290.
- doi: 10.3350/cmh.2014.20.3.283
BACKGROUND/AIMS: To investigate the efficacy and longterm outcome of esophageal variceal ligation (EVL) plus propranolol in comparison with propranolol alone for the primary prophylaxis of esophageal variceal bleeding. METHODS: A total... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
-
Ze E, Baek EK, Lee JJ, Chung HW, Ahn DG, Cho HJ, Kwon JC, Kim HJ, Lee H
- KMID: 2069763
- Clin Mol Hepatol.
- 2014 Sep;20(3):267-273.
- doi: 10.3350/cmh.2014.20.3.267
BACKGROUND/AIMS: Adefovir (ADV) and lamivudine (LAM) combination therapy (ADV+LAM) has been a useful option for patients with LAM-resistant (LAM-r) chronic hepatitis B (CHB). However, the long-term outcomes of LAM+ADV and... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
-
Kim H, Yi NJ, Lee J, Kim J, Moon MR, Jeong J, Lee JM, You TS, Suh SW, Park MS, Choi Y, Hong G, Lee HW, Lee KW, Suh KS
- KMID: 2069766
- Clin Mol Hepatol.
- 2014 Sep;20(3):291-299.
- doi: 10.3350/cmh.2014.20.3.291
BACKGROUND/AIMS: The dose of mycophenolate mofetil (MMF) has been reduced in Asia due to side effects associated with the conventional fixed dose of 2-3 g/day. We aimed to determine the... -
- CITED
-
- Close
- SHARE
-
- Close
